With the development of modern chemistry and biology, non-proteinogenic amino acids
(NPAAs) have become a powerful tool for developing peptide-based drug candidates. Drug …

Neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease
(AD) have no cure and pose a serious threat to human health. The accumulated amyloid has …

Alzheimer's disease (AD) is a major neurodegenerative disorder and the leading cause of
dementia worldwide. Predominantly, misfolding and aggregation of amyloid‐β (Aβ) peptides …

Solvent dynamics strongly induce the fibrillation of an amyloidogenic system. Probing the
solvation mechanism is crucial as it enables us to predict different proteins' functionalities …

Misfolding and aggregation of tau protein, into pathological amyloids, are hallmarks of a
group of neurodegenerative diseases collectively termed tauopathies and their modulation …

Amyloid-β peptide aggregation is a crucial process in neurological disorders such as
Alzheimer's and Parkinson's diseases. Amyloids tend to assemble first into oligomers and …

Aberrant protein misfolding and accumulation is considered to be a major pathological pillar
of neurodegenerative disorders, including Alzheimer's and Parkinson's diseases …

Synthetic antibodies hold great promise in combating diseases, diagnosis, and a wide range
of biomedical applications. However, designing a therapeutically amenable, synthetic …

Antimicrobial peptides (AMPs) are being studied for their potential in addressing microbial
resistance, a significant issue in treating infections. More than 22,500 AMPs are listed in the …

The self‐assembly properties of all possible stereoisomers of terminally protected Boc‐Val‐
Phe‐Phe‐OMe, having sequence homogeneity with Alzheimer's amyloid‐beta (Aβ18‐20) …